Skip to content

Clinical Observation of Intranasal Premedication with Dexmedetomidine for Opioid-Free General Anesthesia during the Induction Period of Tracheal Intubation

Clinical Observation of Different Administration Routes of Intranasal Dexmedetomidine for Opioid-Free General Anesthesia during the Induction Period of Tracheal Intubation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600125319
Enrollment
Unknown
Registered
2026-05-25
Start date
2026-06-01
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ureteral calculi

Interventions

intranasal drops(Group D ) :At 20 minutes before anesthesia induction, dexmedetomidine 1 µg/kg was administered via intranasal drops, with the solution divided equally between both nostrils and instil
Spray group (Group P):At 20 minutes before anesthesia induction, dexmedetomidine 1 µg/kg was administered via intranasal spray. The spray nozzle was directed toward the lateral wall of the nasal cavit

Sponsors

Huai'an Fifth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18–65 years; 2. Scheduled for elective transurethral holmium laser lithotripsy for ureteral calculi under general anesthesia with tracheal intubation; 3. American Society of Anesthesiologists (ASA) physical status classification I–III; 4. Body mass index (BMI) 18–28 kg/m²; 5. Patients and their families provided informed consent, voluntarily participated, and signed written informed consent forms.

Exclusion criteria

Exclusion criteria: 1. Severe cardiac insufficiency, arrhythmia, poorly controlled hypertension, severe bradycardia (HR 3 times the upper limit of normal, Cr > 177 µmol/L); 5. Allergy or contraindication to dexmedetomidine, propofol, esketamine, lidocaine, rocuronium, or other study-related medications; 6. Anticipated difficult airway (Mallampati class III–IV); 7. Long-term preoperative use of sedatives, analgesics, or sympatholytic agents.

Design outcomes

Primary

MeasureTime frame
Heart rate;

Secondary

MeasureTime frame
Systolic blood pressure;Diastolic blood pressure;Mean arterial pressure;Bispectral Index;Anesthesia induction time;Extubation time;Ramsay Sedation Score at 10 minutes after extubation;Total intraoperative propofol consumption;

Countries

China

Contacts

Public ContactSun Xiaojing

Huai'an Fifth People's Hospital

1161601971@qq.com+86 159 9616 3961

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 11, 2026